Lv1
90 积分 2024-06-24 加入
Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapy
1个月前
已完结
Advancements in gene editing technologies for probiotic-enabled disease therapy
1个月前
已完结
Effects of Radiotherapy in Normal Tissue
1个月前
已完结
Bioinspired oral delivery of gut microbiota by self-coating with biofilms
1个月前
已完结
Genetically Programmable Self‐Regenerating Bacterial Hydrogels
2个月前
已完结
Divergent tumor immunity determined by bacteria-cancer cell engagement
2个月前
已完结
A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
3个月前
已完结
Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C
3个月前
已关闭
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
3个月前
已完结
Phase I study evaluating high-dose treatment with ADXS11-001, a Listeria monocytogenes-listeriolysin O (Lm-LLO) immunotherapy, in women with cervical cancer
3个月前
已关闭
皖公网安备34019202002308
